HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Estee Lauder stock offering

This article was originally published in The Rose Sheet

Executive Summary

Offering of approximately 11.3 mil. shares of Class A common stock, priced at $44.50 per share, by three Lauder family trusts did not result in the sale of any shares, and the firm will receive no proceeds from the offering, company reports June 8. Offering, announced May 18, was expected to provide funds "to pay estate taxes and meet other obligations" following the recent death of Lauder's Founding Chairman Estee Lauder (1"The Rose Sheet" May 24, 2004, In Brief). Transaction is scheduled to close June 14. Separately, firm announces June 7 it has been named a defendant in litigation brought by the New York state attorney general's office with respect to hazardous waste dumped at a landfill in Islip, New York. While the company may be liable for part of the cost of the investigation and cleanup, which is estimated by the attorney general to be $16 mil., Lauder does not believe the issue will have "material adverse effect" on finances...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012206

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel